UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000001132
Receipt number R000001378
Scientific Title Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group
Date of disclosure of the study information 2008/04/28
Last modified on 2019/06/21 20:52:56

No. Disposal Last modified on Item of update
1 Insert 2008/04/24 15:20:30
2 Update 2010/12/08 10:02:53 Name of person sending information
Organization
Division name
Address
3 Update 2012/04/24 09:07:11 Post marketing survey by drug manufacture etc., specified by Japanese law.
4 Update 2012/10/24 09:48:52 Recruitment status
Last follow-up date
5 Update 2014/05/21 11:06:07 Email
Email
Name of person sending information
Name of person sending information
Organization
Address
Address
Email
6 Update 2014/05/21 11:07:18 Address
7 Update 2015/05/29 13:50:51 Division name
Division name
8 Update 2016/03/28 20:24:55 Recruitment status
Last follow-up date
9 Update 2016/05/24 10:00:20 Name of person sending information
Name of person sending information
Division name
Division name
TEL
Email
Name of primary person or sponsor
Organization
10 Update 2018/06/14 10:37:05 Name of person sending information
Name of person sending information
TEL
Email
11 Update 2019/06/21 20:48:37 Randomization unit
Key inclusion criteria
Key exclusion criteria
12 Update 2019/06/21 20:51:42 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Name of primary person or sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
13 Update 2019/06/21 20:52:30 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
14 Update 2019/06/21 20:52:56 Recruitment status
Date of IRB